506 related articles for article (PubMed ID: 23326140)
1. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells.
Guo S; Wang Y; Gao Y; Zhang Y; Chen M; Xu M; Hu L; Jing Y; Jing F; Li C; Wang Q; Zhu Z
Med Sci Monit; 2016 Oct; 22():3951-3960. PubMed ID: 27774979
[TBL] [Abstract][Full Text] [Related]
3. High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway.
Zhuang S; Yu X; Lu M; Li Y; Ding N; Ding Y
J Gynecol Oncol; 2020 Nov; 31(6):e91. PubMed ID: 33078596
[TBL] [Abstract][Full Text] [Related]
4. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
Li M; Cai Y; Zhao H; Xu Z; Sun Q; Luo M; Gu L; Meng M; Han X; Sun H
Tumour Biol; 2015 Jun; 36(6):4785-92. PubMed ID: 25647262
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas.
Bao G; Qiao Q; Zhao H; He X
World J Surg Oncol; 2010 Jun; 8():52. PubMed ID: 20579387
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.
Chen X; Zhao G; Wang F; Gao F; Luo H; Wang Y; Du Y; Chen X; Xue C; Dong Z; Song G
Tumour Biol; 2014 Nov; 35(11):11081-9. PubMed ID: 25095979
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer.
Fang J; Ge X; Xu W; Xie J; Qin Z; Shi L; Yin W; Bian M; Wang H
J Cell Physiol; 2020 Apr; 235(4):3438-3446. PubMed ID: 31621076
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of HMGB3 expression in patients with non-small cell lung cancer.
Song N; Liu B; Wu JL; Zhang RF; Duan L; He WS; Zhang CM
Tumour Biol; 2013 Oct; 34(5):2599-603. PubMed ID: 23609034
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G
Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721
[TBL] [Abstract][Full Text] [Related]
11. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic Value of PCMT1 Expression in Gastric Cancer and Its Regulatory Effect on Spindle Assembly Checkpoints].
Wang Y; Zhang M; Zhang Z; Li B; Huang J; Li J; Geng Z; Zhang X; Song X; Wang L; Zuo L; Hu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1167-1175. PubMed ID: 38162070
[TBL] [Abstract][Full Text] [Related]
13. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of
Zheng WJ; Yao M; Fang M; Wang L; Dong ZZ; Yao DF
World J Gastroenterol; 2018 Aug; 24(32):3650-3662. PubMed ID: 30166860
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma.
Sun GG; Hu WN; Cui DW; Zhang J
Tumour Biol; 2014 Mar; 35(3):2631-9. PubMed ID: 24248541
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
Tang C; Gao X; Liu H; Jiang T; Zhai X
Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
[TBL] [Abstract][Full Text] [Related]
18. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma.
Gao J; Zou Z; Gao J; Zhang H; Lin Z; Zhang Y; Luo X; Liu C; Xie J; Cai C
Int J Clin Exp Pathol; 2015; 8(1):345-52. PubMed ID: 25755721
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
